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Background:Hypertension remains uncontrolled despite availabil-
ity of newer drugs, and it accounts for signiﬁcant morbidity and
mortality in India and many developing nations. Resistant hyper-
tension is very common problem in India.
Objective: To evaluate the patient proﬁle, co-morbidities, manage-
ment with anti-hypertensive medications in resistant hyperten-
sion across India.
Method: A total of 4725 uncontrolled hypertensive patients who
were on anti-hypertensive medications were evaluated in a cross-
sectional, observational study. The observed patterns were
recorded with respect to demographics, medical history, anti-
hypertensive medications, lifestyle modiﬁcations, and concomi-
tant medications.
Result: Out of 4725 subjects, 922 (19.5%) subjects had resistant
hypertension. Majority (67.2%) of the patients were males, aged
46–55 (40.5%) and 56–65 years (39.6%). Themean age of the patients
was 52.6 (8.25) years. Majority of the patients were residents from
the state of Andhra Pradesh (21.4%) andMaharashtra (19.3%). More
than 20% were post graduates and 52.2% of the patients were
employed. Mean systolic and diastolic blood pressure was
158.83/97.89 mmHg. 78.9% of the patients had reported co-morbid-
ities. Diabetes (46.9%) and dyslipidemia (20.8%) weremain ongoing
co-morbid conditions.
Most of the patients (79.4%) were on three combination anti-
hypertensive therapy followed by four combination (18.1%).
71.3% of the patients used CCB + ARB + diuretics three combina-
tion anti-hypertensive therapy.
Proportion of resistant hypertensive patients taking three or more
anti-hypertensive medications (n = 922).
Conclusion: Resistant hypertension ismost often due to a failure to
treat hypertension appropriately. The preferred anti-hypertensive
therapy for resistant hypertension patients is triple combination of
anti-hypertensive regimen ARB + CCB + Diuretics. Patients may
require four or more classes of antihypertensive drugs, some at
high doses, to achieve control.
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Background:Hypertension remains uncontrolled despite availabil-
ity of newer drugs, and it accounts for signiﬁcant morbidity and
mortality in India and many developing nations.
Objective: To evaluate the patient proﬁle, co-morbidities, manage-
ment with anti-hypertensive medications in uncontrolled hyper-
tension patients and also to determine the number of patientswith
resistant hypertension across India.
Method: A total of 4725 uncontrolled hypertensive patients who
were on anti-hypertensive medications were evaluated in a cross-
sectional, observational study. The observed patterns were
recorded with respect to demographics, medical history, anti-
hypertensive medications, lifestyle modiﬁcations and concomi-
tant medications.
Results: Majority of the patients in the study were males (71.4%).
Most of the patient population was either overweight (46%) or
obese (24.8%). All patients had ongoing co-morbid condition of
diabetes, dyslipidemia, chronic kidney disease, congestive heart
failure, hormone replacement therapy in females and ischemic
heart disease. Diabetes (33.7%) and dyslipidemia (10.5%) were the
two main co-morbidities observed largely. Most of the patients
were treated with mono (45.4%), dual (31.7%) or triple combination
(8.6%) therapy of anti-hypertensive agents. ARB was the most
preferred agent as monotherapy (70.6%) and also the most com-
mon component of dual and triple combination anti-hypertensive
agent.
Conclusion: Co-morbidities such as dyslipidemia or diabetes were
majorly associated with uncontrolled hypertension. Monotherapy
was leading trends of anti-hypertensive therapy followed by dual
and triple combination therapy. The preferred choices for mono
therapy, dual and triple combination of anti-hypertensive regi-
mens were ARBs, ARB + CCB (calcium channel blocker), and ARB
+ CCB + diuretics, respectively.
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